Skip to content
Open access

Predicting prostate cancer mortality using UK Biobank data: a multimodal machine learning approach.

Sep 2026 · European Journal of Cancer Prevention · 0 citations · 24 references
Medicine

TL;DR

The analysis revealed that age and genetics were the primary influencing factors in prostate cancer mortality, and support the utility of multimodal risk modeling while highlighting challenges in clinical translation.

Abstract

Prostate cancer remains a major cause of cancer-related mortality among men worldwide; however, it remains challenging to predict disease progression in individuals. While numerous tools attempt to forecast the likelihood of developing the cancer, fewer studies focus specifically on mortality prediction using population-scale clinical datasets. UK Biobank data were used to develop population-scale predictive models of prostate cancer mortality. The study assessed medical records, blood work, physical measurements, and genetic information of approximately 167 000 males aged 50 and above. A feedforward neural network was compared with logistic regression to determine their effectiveness. The neural network demonstrated substantially stronger predictive performance than logistic regression, achieving a receiver operating characteristic-area under the curve of 0.767 compared with 0.633 and a precision-recall-area under the curve of 0.271 compared with 0.153, respectively. The analysis revealed that age and genetics were the primary influencing factors. Decision curve analysis demonstrated minimal net benefit across clinically relevant thresholds. These findings support the utility of multimodal risk modeling while highlighting challenges in clinical translation.

Read PDF

Similar papers

Cancer Survival Prediction through Multifactorial Analysis with Machine Learning

These results validate the feasibility of applying artificial intelligence to Brazilian hospital oncology records, demonstrating the potential of these models for future clinical decision-support applications within the Unified Health System (SUS).

I. Ribeiro, Rigue Luigi, Mello Rigato et al. · 0 citations
Aug 2026

Comparison and interpretability of machine learning algorithms to predict survival of patients with prostate cancer.

OBJECTIVE To evaluate the performance and interpretability of multiple ML algorithms for survival prediction in prostate cancer (CaP) and to assess whether these approaches can improve upon established clinical risk prediction models. METHODS Using the Surveillance, Epidemiology, and End Results (SEER) 17 Database, w...

Isaac E. Kim, Cecile P. G. Meier-Scherling, S. Zhou et al. · 0 citations
Open access Sep 2026

Predicting disease progression and mortality in prostate cancer using real-world data-driven time-inhomogeneous Markov models

A time-inhomogeneous Markov model using territory-wide electronic medical records from Hong Kong to estimate 10-year disease progression showed strong prediction performance for metastasis-free survival and overall survival, exceeding Cox proportional hazards and random survival forest models.

Jia-Qi Wang, Yuan-Shi Jiao, D. Craig et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.